 |
 |
thx to all who wrote to help me open the newsletter..here's the part on dopamine hci. Joan ----- Original Message ----- From: Joan Hartman To: [log in to unmask] Sent: Monday, August 09, 1999 7:04 PM Subject: medwatch dopamine (again) sorry I forgot to enclosed the email...Joan FYI - The following products had safety-realted labeling changes approved by FDA in June 1999. You can find the summaries at http:/www.fda.gov/medwatch/safety/1999/jun99.htm MedWatch AGGRASTAT (tirofiban HCl) CARDIOQUIN (quinidine polygalacturonate) CRIXIVAN (indinavir sulfate) CUTIVATE (fluticasone propionate) DIOVAN HCT (valsartan/hydrochlorothiazide) DIPENTUM (olsalazine Na) DOPAMINE HCl DOXIL (doxorubicin HCl liposome) ETHYOL (amifostine) FOSAMAX (alendronateNa) HELIDAC (bismuth subsalicylate/metronidazole/tetracycline HCl) ISMO (isosorbide mononitrate) ISORDIL (isosorbide dinitrate) LOTREL (amlodipine besylate/benazepril) NORPLANT (levonorgestrel implants) NORVIR (ritonavir) PHENDIMETRAZINE TARTRATE PREMARIN (conjugated estrogens) PREVEN (levonorgestrel/ethinyl estradiol) PROVENTIL-HFA (albuterol sulfate) PROZAC (fluoxetine) QUINIDINE GLUCONATE REZULIN (troglitazone) VERELAN (verapamil HCl) VIAGRA (sildenafil citrate)